Form 483

FinVector Oy Form 483, 2024-05-28

FDA issued a Form 483 to FinVector Oy on 2024-05-28 with 3 public-safe observations.

483· Form 483 issuedBiologics3 observations

FinVector Oy · Kuopio, Finland · Issued May 28, 2024

Overview

  • 3 public-safe observations are available for this inspection.
  • 3 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

28 May 2024
21 CFR 211.22(c)

Approve or reject procedures or specs

Cited by Gene D Arcy, Lewis K Antwi

28 May 2024
21 CFR 211.67(b)

Written procedures fail to include

Cited by Gene D Arcy, Lewis K Antwi

28 May 2024
21 CFR 211.84(d)(3)

Establish reliability of supplier's C of A

Cited by Gene D Arcy, Lewis K Antwi

Inspected site

FOFinVector OyKuopio, Finland

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.22(c)Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x
21 CFR 211.84(d)(3)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 3 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere